Healthcare Industry Reports

According to the latest report by IMARC Group, titled  “ Formulation Development Outsourcing Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027, ” The global formulation development outsourcing market size reached US$ 21.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 31.8 Billion by 2027, exhibiting at a CAGR of 6.3% during 2022-2027. Formulation development is a major area of drug development that assists in determining the patentability, lifespan, and success of pharmaceutical products. It also includes pre-formulation activities, such as analytical assay development and characterization and excipient screening to enhance the solubility of products. It is generally outsourced to save time and expenses involved in the process. Formulation development outsourcing also offers advantages like compressing deadlines, accessing expertise and providing additional protection against product failure. As the novel coron

According to the latest report by IMARC Group, titled  “ Drug Device Combination Products Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026, ” the market to grow at a CAGR of XX% during 2021-2026. Drug device combination products include medical devices and pharmaceutical ingredients that help deliver the drug to a preferred location in the patient’s body. They comprise drug-eluting stents, infusion pumps, inhalers, transdermal delivery systems, and prefilled syringes. They have minimal side effects and offer advantages like controlled drug administration and improved patient compliance. As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic. Drug Device Combination Products Market Trends:

According to the latest report by IMARC Group, titled  “ Pyrogen Testing Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026, ” the market to grow at a CAGR of XX% during 2021-2026. Pyrogen testing refers to the detection of both endotoxin and non-endotoxin pyrogenic contaminants in aqueous parenteral. It assists in the safety of parenteral pharmaceutical products and medical devices. Pyrogen testing aids in avoiding life-threatening diseases and fatal endotoxic shock induced by pyrogenic substances. Some commonly used methods of pyrogen testing include the Limulus amebocyte lysate (LAL) test, recombinant factor C (rFC) test, rabbit pyrogen test (RPT), etc. As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of t